Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.
about
A Salmonella Typhimurium mutant strain capable of RNAi delivery: higher tumor-targeting and lower toxicity.Complete proteome of a quinolone-resistant Salmonella Typhimurium phage type DT104B clinical strain.Tumor-specifically hypoxia-induced therapy of SPRY1/2 displayed differential therapeutic efficacy for melanoma.Proteomic Findings in Melanoma.Suppression of pancreatic ductal adenocarcinoma growth by intratumoral delivery of attenuated Salmonella typhimurium using a dual fluorescent live tracking systemAngiogenic inhibitors delivered by the type III secretion system of tumor-targeting Salmonella typhimurium safely shrink tumors in mice.The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.Tumor-targeted delivery of a C-terminally truncated FADD (N-FADD) significantly suppresses the B16F10 melanoma via enhancing apoptosis.Systemic administration of attenuated Salmonella typhimurium in combination with interleukin-21 for cancer therapy.Suppression of tumor angiogenesis by targeting the protein neddylation pathway.Expression of recombinant protein using Corynebacterium Glutamicum: progress, challenges and applications.Comparative proteomics analysis reveals roles for FADD in the regulation of energy metabolism and proteolysis pathway in mouse embryonic fibroblast.Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model.Preparation, cellular uptake and angiogenic suppression of shikonin-containing liposomes in vitro and in vivo.Modulation of Salmonella Tumor-Colonization and Intratumoral Anti-angiogenesis by Triptolide and Its Mechanism.
P2860
Q33989955-D7FB2252-98AB-40E2-A655-A9BEF1F8758DQ34158566-7A6864FD-6BBE-486E-B0A3-C215B94BA523Q35402529-49280CF5-130E-46AE-861B-7BCDEFDD5B9DQ36956140-401104C3-EC69-4B70-B334-D7DC700CCBC3Q37146297-E631A854-5126-4554-94AD-FC75ACF91FCEQ37201418-7BAC6B21-35C9-45A2-950B-7BDEA10743B1Q37282599-2AA38BC4-4FA5-445A-8BE0-3745A46E1E40Q37355548-FA8E7CEC-0E9A-4812-9BCA-1DB86A9DD1BBQ37560917-8A4013F1-F3E0-407D-987C-5C4CBE06E114Q37620640-33F21156-BDD0-4CFE-840B-A5FE11E360D6Q38365052-A7AC3027-F2D6-4E1D-95BF-212481BF92B0Q39142808-5BDD16B4-1D5D-4BF3-8CFC-CD7AC80B4BF8Q39447947-06D70199-AFFD-4EA9-AB7D-AF751E018724Q39515337-78C36F7B-92A3-42AB-8AB5-FBFFFDF14CCEQ40980389-97CB4044-3BF7-4E5E-8B62-EA380AE9D33B
P2860
Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Proteomic screening of anaerob ...... nd its antitumor applications.
@ast
Proteomic screening of anaerob ...... nd its antitumor applications.
@en
type
label
Proteomic screening of anaerob ...... nd its antitumor applications.
@ast
Proteomic screening of anaerob ...... nd its antitumor applications.
@en
prefLabel
Proteomic screening of anaerob ...... nd its antitumor applications.
@ast
Proteomic screening of anaerob ...... nd its antitumor applications.
@en
P2093
P2860
P356
P1476
Proteomic screening of anaerob ...... nd its antitumor applications.
@en
P2093
Dongping Wei
Hongqin Zhuang
Jianxiang Chen
Qingang Hu
Shentong Fang
Wenhui Jiang
P2860
P304
M111.009399
P356
10.1074/MCP.M111.009399
P577
2011-04-07T00:00:00Z